Results 181 to 190 of about 61,737 (200)

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Maria Buti, Ewa Janczewska   +2 more
exaly  

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Lancet, The, 2015
Chloe Orkin, Mark Nelson, Christoph J Stephan   +2 more
exaly  

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Nature, 2005
Jordan Feld
exaly  

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

New England Journal of Medicine, 2002
Michael W Fried, K Rajender Reddy, Dieter Häussinger   +2 more
exaly  

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

Life Sciences, 2020
Abdo A. Elfiky
exaly  

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Lancet, The, 2014
Eric Lawitz
exaly  

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2014
Gregory J Dore, Graham R Foster, Michael W Fried   +2 more
exaly  

Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.

Gastroenterology, 2015
M. Charlton, E. Gane, M. Manns, Robert S. Brown, M. Curry, P. Kwo, R. Fontana, R. Gilroy, L. Teperman, A. Muir, J. Mchutchison, W. Symonds, D. Brainard, B. Kirby, H. Dvory‐Sobol, J. Denning, S. Arterburn, D. Samuel, X. Forns, N. Terrault   +19 more
semanticscholar   +1 more source

Ribavirin

Reactions Weekly, 2002
openaire   +1 more source

Ribavirin

Reactions Weekly, 2013
openaire   +2 more sources